Kinetics Mutual Funds, Inc. The Medical Fund (MEDRX) Research
Kinetics Mutual Funds, Inc. The Medical Fund operates as a non-diversified investment vehicle, allocating all of its capital exclusively to the Medical Portfolio, a specific series within the Kinetics Portfolios Trust. The Medical Portfolio is strategically mandated to invest a minimum of 80% of its net assets—inclusive of any funds borrowed for investment purposes—into a range of equity and equity-linked securities. These include common shares, convertible debt instruments, warrants, and other securities sharing characteristics with common stock. The target companies, both domestic and international, are primarily engaged across medical research, pharmaceutical, and medical technology sectors, as well as associated technology industries. A significant emphasis is placed on entities dedicated to cancer research and the development of new drugs.
Market snapshot
- Symbol
- MEDRX
- Price
- $31.22
- Day change
- 0.00%
- Market cap
- $19.4M
- 52-week range
- 31.22-33.26
- Sector
- Financial Services
- Industry
- Asset Management
Peer companies
- Victory US 500 Enhanced Volatility Wtd Index Fund (CUHAX)
- Victory US 500 Enhanced Volatility Wtd Index Fund (CUHCX)
- Fidelity Simplicity RMD 2015 Fund (FIRUX)
- GMO Emerging Domestic Opportunities Fund (GEDTX)
- Janus Henderson Emerging Markets Fund (HEMAX)
- Janus Henderson Emerging Markets Fund (HEMCX)
- Janus Henderson Emerging Markets Fund (HEMIX)
- Janus Henderson Emerging Markets Fund (HEMSX)
Open Kinetics Mutual Funds, Inc. The Medical Fund (MEDRX) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.